Malignant Genitourinary System Neoplasm

Malignant Genitourinary System Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

15,544 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 3,549
Recruiting: 1,935
Ph III recruiting: 225
Growth YoY: +16.5%
Industry share: 22%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 29.7%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1,963)

clinicaltrialsPublishedShowing 301–350 of 704 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07516808	PRISM-NLM: Prostatectomy Intraoperative Surgical Margin Assessment With Non-linear Microscopy	not yet recruiting	N/A	20	Beth Israel Deaconess Medical CenterOTHER	1	Apr 8, 2026	clinicaltrials
NCT07492381	A Prospective, Single-Arm, Pilot Study of the ALPFA BPH PFA System in Men With Low, Intermediate and High-Risk Prostate Cancer	not yet recruiting	N/A	50	ALPFA MedicalINDUSTRY	0	Apr 7, 2026	clinicaltrials